These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28266806)

  • 21. Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.
    Alvares GA; Quintana DS; Whitehouse AJ
    Autism Res; 2017 Jan; 10(1):25-41. PubMed ID: 27651096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin abnormalities in Engrailed-2 knockout mice: New insight relevant for a model of Autism Spectrum Disorder.
    Viaggi C; Gerace C; Pardini C; Corsini GU; Vaglini F
    Neurochem Int; 2015 Aug; 87():34-42. PubMed ID: 26002543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial.
    Wong NM; Dipasquale O; Turkheimer F; Findon JL; Wichers RH; Dimitrov M; Murphy CM; Stoencheva V; Robertson DM; Murphy DG; Daly E; McAlonan GM
    J Psychopharmacol; 2022 Jun; 36(6):723-731. PubMed ID: 35491679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
    Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
    Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
    Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders.
    Israelyan N; Margolis KG
    Pharmacol Res; 2018 Jun; 132():1-6. PubMed ID: 29614380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Association Between Serotonin 1A Receptor, Gray Matter Volume, and Sociability in Healthy Subjects and in Autism Spectrum Disorder.
    Lefevre A; Richard N; Mottolese R; Leboyer M; Sirigu A
    Autism Res; 2020 Nov; 13(11):1843-1855. PubMed ID: 32864880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical roles of serotonin-oxytocin interaction during the neonatal period in social behavior in 15q dup mice with autistic traits.
    Nagano M; Takumi T; Suzuki H
    Sci Rep; 2018 Sep; 8(1):13675. PubMed ID: 30209293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
    Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B
    Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
    Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
    Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
    Laursen HR; Henningsson S; Macoveanu J; Jernigan TL; Siebner HR; Holst KK; Skimminge A; Knudsen GM; Ramsoy TZ; Erritzoe D
    J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effects of oxytocin in autism: Current status of the research].
    Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R
    Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy.
    Tyrer AE; Levitan RD; Houle S; Wilson AA; Nobrega JN; Rusjan PM; Meyer JH
    Acta Psychiatr Scand; 2016 Nov; 134(5):410-419. PubMed ID: 27553523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
    Okamoto Y; Ishitobi M; Wada Y; Kosaka H
    CNS Neurol Disord Drug Targets; 2016; 15(5):564-77. PubMed ID: 27071789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship between Character Traits and In Vivo Cerebral Serotonin Transporter Availability in Healthy Subjects: A High-Resolution PET Study with C-11 DASB.
    Kim JH; Kim HK; Lee SW; Son YD; Kim JH
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa.
    Yokokura M; Terada T; Bunai T; Nakaizumi K; Kato Y; Yoshikawa E; Futatsubashi M; Suzuki K; Yamasue H; Ouchi Y
    Neuroimage Clin; 2019; 23():101928. PubMed ID: 31491815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.